Cart
sales@molnova.com
Vasopressin Receptor
AVP is synthesized in three hypothalamic nuclei. These are the supraoptic nucleus, the paraventricular nucleus, and the suprachiasmatic nucleus. Neurons in the supraoptic nucleus and magnocellular neurons in the paraventricular nucleus are involved in the response to hypertonicity and volume depletion and send axons to the neurohypophysis for vasopressin secretion. AVP exerts its effects on cells through three G-proteincoupled receptors. The V1a and V1b subtypes are coupled to Gq/11 and activate phospholipase C leading to increases in inositol trisphosphate and diacylglycerol with secondary increases in cell calcium and activation of protein kinase C. The V2 receptor activates the Gs-coupled adenyl cyclase system causing increased intracellular levels of cyclic adenosine monophosphate (cAMP). Within the central nervous system, AVP has a number of cognitive and behavioral effects to include regulation of aggression, social recognition, and certain aspects of pair bonding.
References
1.Palmer BF. Curr Hypertens Rep. 2015;17(1):510.
References
1.Palmer BF. Curr Hypertens Rep. 2015;17(1):510.
GPCR/G Protein
ACAT(3)
Angiotensin Receptor(27)
Antibacterial(545)
Bombesin Receptor(13)
Bradykinin Receptor(23)
Calcium Channel(197)
cAMP(16)
Cannabinoid Receptor(88)
CaSR(18)
CGRP Receptor(18)
Chemokine Receptor(104)
Cholecystokinin Receptor(24)
CRF Receptor(14)
Dopamine Receptor(181)
Endothelin Receptor(28)
FFAR(5)
Galanin Receptor(1)
GHSR(20)
Glucagon Receptor(51)
GPCR19(9)
GPR119(3)
Hedgehog (Hh)(35)
Histamine Receptor(139)
Imidazoline Receptor(1)
Leukotriene Receptor(15)
LHR(1)
LPA Receptor(19)
Lysophospholipid Receptor(13)
mAChR(25)
MCHR(8)
Melanocortin Receptor(28)
Melatonin Receptor(7)
mGluR(11)
Motilin Receptor(4)
Neurokinin Receptor(43)
Neuropeptide Y Receptor(44)
Neurotensin Receptor(11)
Orexin Receptor(16)
Other Targets(3)
OXTR(2)
P2Y Receptor(14)
PAR(28)
Platelet-activating Factor Receptor(2)
Prostaglandin Receptor(79)
PTH Receptor(1)
S1P Receptor(35)
SGLT(26)
Somatostatin Receptor(15)
Urotensin Receptor(4)
Vasopressin Receptor(20)
Vasopressin Receptor
-
TASP0390325
catalog no : M34441
cas no: 1642187-96-9
TASP0390325 is an orally active and high affinity arginine pressin receptor 1B (V1B receptor) antagonist that shows antidepressant and anxiolytic activity in animal studies and blocks V1B receptors in the anterior pituitary gland in vivo.
-
OPC-51803
catalog no : M34361
cas no: 192514-54-8
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
-
E-4177
catalog no : M34229
cas no: 135070-05-2
E-4177 is an angiotensin II type 1 receptor (AT1R) antagonist and can be used to study cardiovascular diseases.
-
Fedovapagon
catalog no : M33357
cas no: 347887-36-9
Fedovapagon (VA106483) is a selective and potent agonist of the vasopressin V2 receptor (V2R) that inhibits the growth of intersegmental vessels in zebrafish.
-
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin
catalog no : M30829
cas no: 73168-24-8
Selective vasopressin V1A receptor antagonist. Inhibits vasopressin and oxytocin-induced increases in intracellular calcium concentrations in vitro (IC50 values are 5 and 30 nM respectively). Exhibits potent and prolonged antivasopressor activity and induces anxiolytic-like effects in the dorsal, but not ventral, hippocampus in vivo.